MiR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Yan, Xin ^a,b,c   Chen, Xi ^b   Liang, Hongwei ^b   Deng, Ting ^a   Chen, Weixu ^d   Zhang, Suyang ^b   Liu, Minghui ^b   Gao, Xiujuan ^a   Liu, Yanqing ^b   Zhao, Chihao ^b   Wang, Xueliang ^b   Wang, Nan ^b   Li, Jialu ^a   Liu, Rui ^a   Zen, Ke ^b   Zhang, Chen Yu ^b   Liu, Baorui ^c   Ba, Yi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; ERBB3; Invasion; microRNA; miR 143; miR 145; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 3; MESSENGER RNA; MICRORNA 143; MICRORNA 145; 3' UNTRANSLATED REGION; ERBB3 PROTEIN, HUMAN; MICRORNA; MIRN143 MICRORNA, HUMAN; MIRN145 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; CANCER TISSUE; CELL INVASION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION ASSAY; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; TRANSLATION REGULATION; TUMOR INVASION; TUMOR MODEL; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; C57BL MOUSE; CANCER TRANSPLANTATION; CELL PROLIFERATION; FEMALE; GENETICS; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MALE; MCF-7 CELLS; MICE; MICE, INBRED C57BL; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RECEPTOR, ERBB-3;

EID: 84907404546     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-220     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156. 10.1002/ijc.1440, 11668491.
3. Foley J, Nickerson NK, Nam S, Allen KT, Gilmore JL, Nephew KP, Riese DJ. EGFR signaling in breast cancer: bad to the bone. Semin Cell Dev Biol 2010, 21:951-960. 10.1016/j.semcdb.2010.08.009, 2991402, 20813200.
4. Kruser TJ, Wheeler DL. Mechanisms of resistance to HER family targeting antibodies. Exp Cell Res 2010, 316:1083-1100. 10.1016/j.yexcr.2010.01.009, 20064507.
5. Hamburger AW. The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies. J Mammary Gland Biol Neoplasia 2008, 13:225-233. 10.1007/s10911-008-9077-5, 3709461, 18425425.
6. Sithanandam G, Anderson LM. The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Ther 2008, 15:413-448. 10.1038/cgt.2008.15, 2761714, 18404164.
7. Stern DF. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 2008, 13:215-223. 10.1007/s10911-008-9083-7, 18454306.
8. Xue C, Liang F, Mahmood R, Vuolo M, Wyckoff J, Qian H, Tsai KL, Kim M, Locker J, Zhang ZY, Segall JE. ErbB3-dependent motility and intravasation in breast cancer metastasis. Cancer Res 2006, 66:1418-1426. 10.1158/0008-5472.CAN-05-0550, 16452197.
9. Andorfer CA, Necela BM, Thompson EA, Perez EA. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol Med 2011, 17:313-319. 10.1016/j.molmed.2011.01.006, 21376668.
10. Shi M, Guo N. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. Cancer Treat Rev 2009, 35:328-334. 10.1016/j.ctrv.2008.12.002, 19171434.
11. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355. 10.1038/nature02871, 15372042.
12. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
13. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531. 10.1038/nrg1379, 15211354.
14. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866. 10.1038/nrc1997, 17060945.
15. Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010, 42:1273-1281. 10.1016/j.biocel.2009.12.014, 20026422.
16. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269. 10.1038/nrc1840, 16557279.
17. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070. 10.1158/0008-5472.CAN-05-1783, 16103053.
18. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
19. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y, Ren Z, Zen K, Zhang J, Zhang CY. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009, 28:1385-1392. 10.1038/onc.2008.474, 19137007.
20. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R, Dean NM, Freier SM, Bennett CF, Lollo B, Griffey R. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004, 279:52361-52365. 10.1074/jbc.C400438200, 15504739.
21. Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010, 70:378-387. 10.1158/0008-5472.CAN-09-2021, 2805032, 19996288.
22. Wang S, Bian C, Yang Z, Bo Y, Li J, Zeng L, Zhou H, Zhao RC. miR-145 inhibits breast cancer cell growth through RTKN. Int J Oncol 2009, 34:1461-1466.
23. Zhang W, Wang Q, Yu M, Wu N, Wang H. MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer. Technol Cancer Res Treat 2014, 13:161-168.
24. Cho WC, Chow AS, Au JS. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 2009, 45:2197-2206. 10.1016/j.ejca.2009.04.039, 19493678.
25. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798. 10.1016/S0092-8674(03)01018-3, 14697198.
26. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004, 2:e363. 10.1371/journal.pbio.0020363, 521178, 15502875.
27. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500. 10.1038/ng1536, 15806104.
28. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1007. 10.1016/j.cell.2009.04.021, 2722880, 19524505.
29. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689. 10.1038/nature04303, 16258535.
30. Aurisicchio L, Marra E, Luberto L, Carlomosti F, De Vitis C, Noto A, Gunes Z, Roscilli G, Mesiti G, Mancini R, Alimandi M, Ciliberto G. Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors. J Cell Physiol 2012, 227:3381-3388. 10.1002/jcp.24037, 22213458.
31. Kutanzi KR, Yurchenko OV, Beland FA, Checkhun VF, Pogribny IP. MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics 2011, 2:171-185. 10.1007/s13148-011-0040-8, 3156306,3156306, 21949547.